CDKL5 DEFICIENCY DISORDER
Clinical trials for CDKL5 DEFICIENCY DISORDER explained in plain language.
Never miss a new study
Get alerted when new CDKL5 DEFICIENCY DISORDER trials appear
Sign up with your email to follow new studies for CDKL5 DEFICIENCY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for toddlers with rare epilepsy: ganaxolone trial launches
Disease control Not yet recruitingThis study tests whether adding ganaxolone to standard seizure medicines can reduce seizures in children aged 6 months to 2 years with CDKL5 deficiency disorder (CDD). About 20 children will receive either ganaxolone or a placebo for 12 weeks, followed by an open-label phase wher…
Matched conditions: CDKL5 DEFICIENCY DISORDER
Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Warm baths may tame seizures in rare childhood disorder
Symptom relief Not yet recruitingThis study tests whether daily warm baths at home can safely reduce epileptic seizures in children with CDKL5 deficiency disorder, a rare genetic condition. About 34 children aged 6 months to 14 years with drug-resistant epilepsy will take part. Researchers will measure if seizur…
Matched conditions: CDKL5 DEFICIENCY DISORDER
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Symptom relief
Last updated May 26, 2026 04:17 UTC